References
Bazett HC (1920) An analysis of the time-relations of electrocardiograms. Heart 7:353–370
Péhourcq F (2004) A simple high-performance liquid chromatographic method for detection of hydroxyzine in human plasma after overdose. J Pharmacol Toxicol Methods 50:41–44. doi:10.1016/j.vascn.2004.01.001
Yap YG, Camm J (2000) Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation. BMJ 320:1158–1159
Hulhoven R, Rosillon D, Letiexhe M et al (2007) Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. Eur J Clin Pharmacol 63:1011–1017. doi:10.1007/s00228-007-0366-5
Sakaguchi T, Itoh H, Ding W-G et al (2008) Hydroxyzine, a first generation H(1)-receptor antagonist, inhibits human ether-a-go-go-related gene (HERG) current and causes syncope in a patient with the HERG mutation. J Pharmacol Sci 108:462–471
Lee BH, Lee SH, Chu D et al (2011) Effects of the histamine H(1) receptor antagonist hydroxyzine on hERG K(+) channels and cardiac action potential duration. Acta Pharmacol Sin 32:1128–1137. doi:10.1038/aps.2011.66
ANSM—French national pharmacovigilance database, since 1985
CredibleMeds (2014) https://www.crediblemeds.org/new-drug-list/. Accessed 23 Nov 2014
Conflicts of interest
There are no competing interests to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vigne, J., Alexandre, J., Fobe, F. et al. QT prolongation induced by hydroxyzine: a pharmacovigilance case report. Eur J Clin Pharmacol 71, 379–381 (2015). https://doi.org/10.1007/s00228-014-1804-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-014-1804-9